167 related articles for article (PubMed ID: 12032450)
1. [The role of aromatase inhibitors in the treatment of breast neoplasms. An evaluation of clinical efficacy and the tolerability profile].
Porpiglia M; Genta F; Vicelli R; De Nicola B; Ferraris F; Piccinno R; Benedetto C
Minerva Ginecol; 2002 Apr; 54(2):115-31. PubMed ID: 12032450
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Hamilton A; Volm M
Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
[TBL] [Abstract][Full Text] [Related]
3. [Advancement in endocrine therapy for breast cancer].
Yang MT; Lian ZQ
Ai Zheng; 2007 Apr; 26(4):440-4. PubMed ID: 17430670
[TBL] [Abstract][Full Text] [Related]
4. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors in breast cancer: an update.
Lake DE; Hudis C
Cancer Control; 2002; 9(6):490-8. PubMed ID: 12514567
[TBL] [Abstract][Full Text] [Related]
7. [The ATAC study on adjuvants in breast cancer].
Bravi S
Suppl Tumori; 2004; 3(4):S15. PubMed ID: 15206200
[No Abstract] [Full Text] [Related]
8. Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?
Freedman OC; Verma S; Clemons MJ
Cancer Treat Rev; 2005 Feb; 31(1):1-17. PubMed ID: 15707700
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?
Clemons M; Coleman RE; Verma S
Cancer Treat Rev; 2004 Jun; 30(4):325-32. PubMed ID: 15145507
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors as adjuvant therapy in breast cancer.
Visvanathan K; Davidson NE
Oncology (Williston Park); 2003 Mar; 17(3):335-42, 347; discussion 347-50, 354. PubMed ID: 12661266
[TBL] [Abstract][Full Text] [Related]
11. Antiaromatase agents: evolving role in adjuvant therapy.
Jones SE
Clin Breast Cancer; 2002 Apr; 3(1):33-42. PubMed ID: 12020394
[TBL] [Abstract][Full Text] [Related]
12. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.
Morandi P; Rouzier R; Altundag K; Buzdar AU; Theriault RL; Hortobagyi G
Cancer; 2004 Oct; 101(7):1482-9. PubMed ID: 15378476
[TBL] [Abstract][Full Text] [Related]
13. [The ATAC study on adjuvants in breast cancer. What kind of repercussions will it have on clinical practice?].
Gamucci T
Suppl Tumori; 2004; 3(4):S16. PubMed ID: 15206201
[No Abstract] [Full Text] [Related]
14. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
15. [Antiestrogen therapy in the treatment of breast neoplasms].
Alba E; Ragonesi G; Colla F; Mazzoleni A; Farina C
Minerva Ginecol; 2002 Jun; 54(3):245-51. PubMed ID: 12063440
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer.
Arora A; Potter JF
J Am Geriatr Soc; 2004 Apr; 52(4):611-6. PubMed ID: 15066080
[TBL] [Abstract][Full Text] [Related]
17. The current status of aromatase inhibitors in the management of breast cancer.
Baum M; Buzdar A
Surg Clin North Am; 2003 Aug; 83(4):973-94. PubMed ID: 12875605
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant hormone therapy for breast cancer: alternatives to tamoxifen.
Prescrire Int; 2005 Jun; 14(77):108-10. PubMed ID: 15984106
[TBL] [Abstract][Full Text] [Related]
19. [Controversies in endocrine therapy for breast cancer].
Kawakami M; Saji S; Toi M
Gan To Kagaku Ryoho; 2004 Feb; 31(2):181-7. PubMed ID: 14997748
[TBL] [Abstract][Full Text] [Related]
20. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
Wu K; Brown P
J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
[No Abstract] [Full Text] [Related]
[Next] [New Search]